GLP1 agonists are a very important management option- GPs who have not yet used this class of medications should learn more and start
They are potent in lowering blood glucose levels and weight. Given once a week and have non-glycaemic cardiovascular benefits
There are few contraindications and can be used in patients with very low eGFR
GLP1 agonists can be used as second-line after metformin, third line and some can also be used with insulin

 

Host: Dr David Lim | Total time: 38 mins

Guest: A/Prof Neale Cohen, Endocrinologist; Director of Clinical Diabetes, the Baker Heart and Diabetes Institute, Melbourne

 





Register for our fortnightly FREE WEBCASTS

Every second Tuesday | 7:00pm-9:00pm AEDT

Click here to register for the next one

<ul>
<li>GLP1 agonists are a very important management option- GPs who have not yet used this class of medications should learn more and start</li>
<li>They are potent in lowering blood glucose levels and weight. Given once a week and have non-glycaemic cardiovascular benefits</li>
<li>There are few contraindications and can be used in patients with very low eGFR</li>
<li>GLP1 agonists can be used as second-line after metformin, third line and some can also be used with insulin</li>
</ul>
&nbsp;
Host:&nbsp;Dr David Lim |&nbsp;Total time: 38 mins
Guest: A/Prof Neale Cohen, Endocrinologist; Director of Clinical Diabetes, the Baker Heart and Diabetes Institute, Melbourne
&nbsp;
 
Register for our fortnightly FREE WEBCASTS
Every second Tuesday | 7:00pm-9:00pm AEDT
<a href="https://www.healthed.com.au/webcast/">Click here to register for the next one</a>

Healthed's medical education channel features the latest high quality clinical interviews and lectures from leading experts in their field, offering health professionals a convenient new way to boost their knowledge.

Advertisement